Author: Garcia-Vidal, Carolina; Cózar-Llistó, Alberto; Meira, Fernanda; Dueñas, Gerard; Puerta-Alcalde, Pedro; Cilloniz, Catia; Garcia-Pouton, Nicole; Chumbita, Mariana; Cardozo, Celia; Hernandez, Marta; Rico, Veronica; Bodro, Marta; Morata, Laura; Castro, Pedro; Almuedo-Riera, Alex; GarcÃa, Felipe; Mensa, Josep; Antonio MartÃnez, José; Sanjuan, Gemma; Torres, Antoni; Nicolas, JM; Soriano, Alex
Title: Trends in mortality of hospitalised COVID-19 patients: a single centre observational cohort study from Spain Cord-id: vpfk7cgp Document date: 2021_1_24
ID: vpfk7cgp
Snippet: Background We aimed to describe changes in characteristics and treatment strategies of hospitalised patients with COVID-19 and detail the mortality trend over time. Methods Observational cohort study of all consecutive patients admitted ≥ 48 hours to Hospital Clinic of Barcelona for COVID-19 (1 March – 30 September 2020). Findings A total of 1645 consecutive patients with COVID-19 were assessed over a 7-month period. Overall mortality (≤30 days) was 9•7% (159 patients), 7•7% in patient
Document: Background We aimed to describe changes in characteristics and treatment strategies of hospitalised patients with COVID-19 and detail the mortality trend over time. Methods Observational cohort study of all consecutive patients admitted ≥ 48 hours to Hospital Clinic of Barcelona for COVID-19 (1 March – 30 September 2020). Findings A total of 1645 consecutive patients with COVID-19 were assessed over a 7-month period. Overall mortality (≤30 days) was 9•7% (159 patients), 7•7% in patients hospitalised in regular wards and 16•7 % in patients requiring ICU admission. Overall mortality decreased from 11•6% in the first month to 1•4% in the last month, reflecting a progressive, significant downward trend (p for trend <0•001). Patients’ age changed over time, peaking in June. Most changes in the use of antivirals and anti-inflammatory treatments were documented. Age (OR 1•1, CI 1•1-1•12), chronic heart disease, (OR 1•7, CI 1•1-2•9), D-dimer>700 ng/mL (OR 2•3, CI 1•3-4•1), ferritin>489 ng/mL (OR 1•9; CI 1•5-3•2), C-RP>7 mg/dL (OR 2•6; CI 1•5-4•6), and shorter duration from symptom onset to hospital admission (OR 1•11; CI 1•04-1•17) were factors associated with 30-day mortality at hospital admission. Conversely, hospital admission in the last months (OR 0•80; CI 0•65-0•98) was significantly associated with lower mortality. Interpretation In-hospital mortality has decreased in patients with COVID-19 over the last, few months, even though main patient characteristics remain similar. Several changes made when managing patients may explain this decreasing trend. Our study provides current data on mortality of patients hospitalised with COVID-19 that might be useful in establishing quality of standard of care. Funding EIT Health, European Union´s Horizon 2020 Research and Innovation Programme), EDRD. PPA [CM18/00132], NGP [FI19/00133], and CGV [FIS PI18/01061], have received grants from Ministerio de Sanidad y Consumo, ISCIII.
Search related documents:
Co phrase search for related documents- academic hospital and lopinavir ritonavir hydroxychloroquine: 1
- academic hospital and low mortality: 1
- academic hospital and low mortality rate: 1
- academic hospital and low number: 1, 2
- academic hospital and lung disease: 1, 2, 3, 4
- academic hospital and lymphocyte count: 1, 2, 3, 4
- lopinavir ritonavir and low mortality: 1, 2, 3, 4, 5, 6, 7, 8
- lopinavir ritonavir and low mortality rate: 1, 2
- lopinavir ritonavir and low number: 1
- lopinavir ritonavir and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
- lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- lopinavir ritonavir hydroxychloroquine and low mortality: 1, 2, 3
- lopinavir ritonavir hydroxychloroquine and low mortality rate: 1
- lopinavir ritonavir hydroxychloroquine and lung disease: 1, 2, 3
- lopinavir ritonavir hydroxychloroquine and lymphocyte count: 1, 2
- low mortality and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- low mortality and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- low mortality rate and lung disease: 1
- low mortality rate and lymphocyte count: 1, 2
Co phrase search for related documents, hyperlinks ordered by date